Introduction: Despite the unquestionable success of antiretroviral therapy achieved in recent years, there are still cases of heavily treated patients who do not achieve or struggle to maintain undetectable HIV-RNA due to drug resistance. New antiretroviral options are needed to address this issue.Area covered: The authors first provide an...
-
2021 (v1)PublicationUploaded on: February 11, 2024
-
2020 (v1)Publication
Purpose of Review In this narrative review, we discuss key questions about the antifungal treatment of complicated intrabdominal infections (cIAI). Recent Findings Although less common than bacteria,Candidaspp. are not an infrequent cause of cIAI. Considering that invasive abdominal candidiasis (IAC) may be accompanied by septic shock in up to...
Uploaded on: October 27, 2024 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2022 (v1)Publication
Aim of this study was to assess the predictors of virological failure (VF) among patients living with HIV (PLWHIV) switching from an effective first-line antiretroviral therapy (ART) regimen, and to evaluate the emergence of resistance-associated mutations. All adult patients enrolled in the Antiviral Response Cohort Analysis cohort who started...
Uploaded on: April 15, 2023 -
2022 (v1)Publication
Rapid start of antiretroviral therapy (ART) pending genotypic resistance test (GRT) has been recently proposed, but the effectiveness of this strategy is still debated. The rate of virological success (VS), defined as HIV-RNA < 50 copies/ml, with and without GRT was compared in drug-naïve individuals enrolled in the Italian ARCA cohort who...
Uploaded on: March 27, 2023 -
2021 (v1)Publication
BACKGROUND: The primary objective of the study is to describe the cellular characteristics of bronchoalveolar lavage fluid (BALF) of COVID-19 patients requiring invasive mechanical ventilation; the secondary outcome is to describe BALF findings between survivors vs non-survivors.MATERIALS AND METHODS: Patients positive for SARS-CoV-2 RT PCR,...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Coronavirus disease 2019 (COVID-19) can lead to respiratory failure due to severe immune response. Treatment targeting this immune response might be beneficial but there is limited evidence on its efficacy. The aim of this study was to determine if early treatment of patients with COVID-19 pneumonia with tocilizumab and/or steroids was...
Uploaded on: April 14, 2023